Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06460272 · ClinicalTrials.gov registry record · NA

Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support

A NA study of Obesity and Hypertension, sponsored by Amanda Shallcross.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT06460272: Completed NA study of Obesity and Hypertension, sponsored by Amanda Shallcross.

NCT06460272 is a NA study of Obesity and Hypertension that has completed, run by Amanda Shallcross. The registered enrollment target is 75 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06460272, a NA study of Obesity and Hypertension, has completed, sponsored by Amanda Shallcross.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This study is a human-centered, three-arm, parallel-group, randomized control, implementation trial (n=75) to compare MTM (Medically Tailored Meals) only (14 meals delivered weekly for 10 weeks) vs. MTM + SMA (Shared Medical Appointments; once weekly sessions for 10 weeks) vs. a wait-list control group (MTM-Later) in patients with hypertension, type 2 diabetes, obesity, and/or metabolic syndrome. All intervention components will be culturally congruent (e.g., MTMs will include food that converges with culturally relevant diets and SMAs will be delivered by individuals with racial concordance to the target community). Primary outcomes will be implementation (recruitment and retention rates) and feasibility (engagement and satisfaction). Participants will be recruited from Cleveland Clinic's South Pointe Hospital in Warrensville Heights, a predominantly Black community with low socioeconomic status and high cardiovascular disease morbidity.

Primary Outcome

Recruitment is a measure of treatment implementation. Recruitment rate will be measured by # of participants enrolled in study/# passed eligibility screening.

Interventions

  • OTHER Medically Tailored Meals

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2024-07-30
Est. Completion 2025-03-06
Phase NA
Amanda Shallcross

2 total trials

What the finished NCT06460272 record still lists

NCT06460272 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Medically Tailored Meals is the first listed.

NCT06460272 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06460272 about?

NCT06460272 is a clinical study titled "Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support". This study is a human-centered, three-arm, parallel-group, randomized control, implementation trial (n=75) to compare MTM (Medically Tailored Meals) only (14 meals delivered weekly for 10 weeks) vs. MTM + SMA (Shared Medical Appointments; once weekly sessions for 10 weeks) vs. a wait-list control gr...

What is the current status of trial NCT06460272?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2024-07-30. Estimated completion is 2025-03-06.

What conditions does trial NCT06460272 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Type 2 Diabetes, Metabolic Syndrome.

What interventions are being tested in trial NCT06460272?

The interventions under investigation include: Medically Tailored Meals (OTHER).

Who is sponsoring clinical trial NCT06460272?

This trial is sponsored by Amanda Shallcross, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06460272 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06460272's enrollment target sits among peer trials

75 570th of 1053 higher than 481 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06460272, the US trial registry maintained by the National Library of Medicine. NCT06460272 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.